Krystal Biotech buy Chardan Capital
Start price
20.02.25
/
50%
€172.25
Target price
20.02.26
€208.60
Performance (%)
-19.71%
Price
25.09.25
€138.30
Summary
This prediction is currently active. The price of Krystal Biotech has decreased since the start of the prediction. Compared to the start price this results in a performance of -19.71%. This prediction currently runs until 20.02.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 1.505% | 1.505% |
| iShares Core DAX® | -0.581% | -2.940% |
| iShares Nasdaq 100 | 0.824% | 3.718% |
| iShares Nikkei 225® | -0.630% | 5.126% |
| iShares S&P 500 | 0.643% | 2.253% |
Comments by Chardan_Capital for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its price target raised by analysts at Chardan Capital from $212.00 to $218.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Chardan_Capital for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€118.80
05.08.25
05.08.25
€189.46
05.08.26
05.08.26
16.41%
25.09.25
25.09.25
Krystal Biotech
Start price
Target price
Perf. (%)
€116.70
07.05.25
07.05.25
€193.05
07.05.26
07.05.26
18.51%
25.09.25
25.09.25
Krystal Biotech
Start price
Target price
Perf. (%)
€151.90
18.12.24
18.12.24
€202.14
18.12.25
18.12.25
-8.95%
25.09.25
25.09.25
Krystal Biotech
Start price
Target price
Perf. (%)
€165.85
12.12.24
12.12.24
€201.99
12.12.25
12.12.25
-16.61%
25.09.25
25.09.25